News
Source-attributed headlines with timestamps and links to the companies and crypto markets they mention.
Latest Coverage
30 headlines
Gainers GMEX Robotics (NASDAQ:GMEX) stock increased by 14.8% to $0.85 during Tuesday's pre-market session. Crown Crafts (NASDAQ:CRWS) stock increased by 10.29% to $3.0. The market value of their outstanding shares
Gainers iSpecimen (NASDAQ:ISPC) stock increased by 22.7% to $1.89 during Tuesday's pre-market session. The company's market cap stands at $3.8 million. Bluejay Diagnostics (NASDAQ:BJDX) shares moved upwards by
Gainers CEA Industries (NASDAQ:BNC) shares rose 40.4% to $4.9 during Tuesday's pre-market session. The company's market cap stands at $143.6 million. Hadron Energy (NASDAQ:HDRN) shares increased by 13.96% to
Gainers Arbe Robotics (NASDAQ:ARBE) shares rose 43.6% to $0.91 during Tuesday's pre-market session. The company's market cap stands at $80.9 million. Mobix Labs (NASDAQ:MOBX) stock rose 8.59% to $1.01. The
General Mills (NYSE:GIS) affirms FY2027 Adj EPS guidance from $3.00-$3.20 to $3.00-$3.20 vs $3.08 analyst estimate. Guides FY2027 Organic Net Sales Down 1.5% To Up 0.5%.
TruGolf Holdings, Inc. (Nasdaq: TRUG) today announced that it has entered into a legally binding Memorandum of Understanding with TruGolf Canada Inc. The MOU appoints TruGolf Canada Inc. as TruGolf’s exclusive master
Filed: 2026-09-08 AccNo: 0001493152-26-041706 Size: 247 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Filed: 2026-09-08 AccNo: 0001104659-26-105687 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
In silico modeling predicts robust AP01 distribution in healthy and fibrotic lungs, even in severe diseasePatient survey findings suggest that clear communication, transparent discussions of potential benefits and
Liberty Global (NASDAQ: LBTYA, LBTYB and LBTYK) today announced that it has agreed to sell VodafoneZiggo's tower assets to an entity to be jointly owned by funds managed by DigitalBridge, TD Greystone Infrastructure
Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (NASDAQ:LUCY, LUCYW))), the developer and manufacturer of smart eyewear under the Lucyd®, Lucyd Armor®, Reebok®, Nautica® and Eddie Bauer®
BMO Capital analyst Jeffrey Silber initiates coverage on Andersen Group (NYSE:ANDG) with a Market Perform rating and announces Price Target of $58.
Aduro Clean Technologies Inc. ("Aduro" or the "Company") (Nasdaq: ADUR) (TSX: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste
Johnson & Johnson (NYSE:JNJ) today announced that 24 abstracts featuring clinical data and real-world evidence across the neuropsychiatry portfolio will be presented at the 2026 Psych Congress Annual Meeting
https://www.wsj.com/finance/currencies/robinhood-strikes-deal-with-crypto-com-in-latest-prediction-markets-push-901a32aa
Filed: 2026-09-08 AccNo: 0001636282-26-000113 Size: 237 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Baird analyst Colin Sebastian maintains Airbnb (NASDAQ:ABNB) with a Outperform and raises the price target from $175 to $200.
Rigetti Computing (RGTI) stock jumped 6% premarket after securing $100M in U.S. CHIPS Act funding for quantum computing R&D. Read more.
Analysts initiated coverage with Buy ratings on SpaceX, Securitize ; Overweight on Londian Wason.
U.S. stock futures fell as Novartis plunged 12.7% after pelacarsen’s Phase III trial missed its endpoint; other biotech stocks also declined.
Novartis stock falls following Phase 3 clinical trial failures for del-desiran and pelacarsen, impacting Ionis and Royalty Pharma shares.
Filed: 2026-09-08 AccNo: 0001477932-26-005436 Size: 155 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Filed: 2026-09-08 AccNo: 0001493152-26-041704 Size: 6 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Filed: 2026-09-08 AccNo: 0001213900-26-097851 Size: 187 KB Item 8.01: Other Events
Dyne Therapeutics, Inc. (NASDAQ:DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that it will present